Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93970efbfe7933d6a3a2b73fda5fdd77 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
filingDate |
2007-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39b22af0a08f7eb5a9d51301980e8d15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7000ec815541b0d50c5c68303d6b9ba2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70349660c304129953ad492e80beb7cf |
publicationDate |
2009-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2074993-A1 |
titleOfInvention |
Venlafaxine-containing film-coated modified-release tablets |
abstract |
The present invention relates to a modified release composition of at least one form of venlafaxine, which is an enhanced absorption delayed controlled release composition. The composition comprises a core comprising at least one form of venlafaxine, less than 10% of a gelling agent and a pharmaceutically acceptable excipient. The composition further comprises a modified release coating which substantially surrounds the core which provides a delayed controlled release of the at least one form of venlafaxine. |
priorityDate |
2007-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |